Skip to main content

NASDAQ: AGRX Agile Therapeutics Anticipates Increased Growth In Q3 of 2022

Contact Details

Matt Riley - Head of Investor Relations & Corporate Communications

mriley@agiletherapeutics.com

Company Website

https://agiletherapeutics.com/

Recent Quotes

View More
Symbol Price Change (%)
AMZN  208.44
+3.17 (1.54%)
AAPL  272.24
+6.06 (2.28%)
AMD  214.07
+17.47 (8.89%)
BAC  50.27
-0.80 (-1.56%)
GOOG  311.36
-0.33 (-0.11%)
META  638.95
+1.70 (0.27%)
MSFT  388.62
+4.15 (1.08%)
NVDA  193.60
+2.05 (1.07%)
ORCL  146.02
+4.71 (3.33%)
TSLA  410.55
+10.72 (2.68%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.